I think the major takeaway from the webinar is that their aim is...

I think the major takeaway from the webinar is that their aim is to have 200m shares outstanding after the equity investment.
that’s 40% dilution which is nowhere near the 100% or greater that all of the naysayers have been quoting. Francis did say that it is by no means guaranteed but that it is his/their firm aim .

imo they could only feel that way if they were confident of a strong grant to support the financing as well as further ECA support from within Europe.

they reiterated many times the equity investment will be at project level. However further financing needs as the project moves along may be at project or company level depending on phase 2 needs (a long way off) .

the LEOP on track for first lithium end of march, production tweaks and fine tuning happening now.

another big takeaway- there is interest in licensing vulsorb and talks are happening currently. They’re confident in the opportunities that lay ahead on the technology licensing front.

expansion opportunities (both current resource and future projects) also currently being evaluated.

overall a very positive update.